Serum Glial Cell Line-Derived Neurotrophic Factor (sGDNF) Is a Novel Biomarker in Predicting Cirrhosis in Patients with Chronic Hepatitis B

Figure 1

Receiver operating characteristics (ROC) analysis showing the predictive value of sGDNF for liver fibrosis in patients with CHB. Receiver operating characteristic curve for sGDNF predicting liver fibrosis (a) and cirrhosis (b). The estimates indicate the area under the ROC curve.

(a)

(b)